Related Experiment Videos

Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells

Guangfeng Zhang1, Naveena Yanamala, Kira L Lathrop

  • 1Division of Endocrinology and Metabolism, University of Pittsburgh, E1115 Starzl Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15261, USA.

Insights

Mitochondrial estrogen receptor beta (ERbeta) plays a key role in non-small-cell lung cancer apoptosis. This ERbeta form regulates apoptosis independently of estrogen, interacting with the Bad protein to control cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Estrogen receptor (ER)beta has been identified in mitochondria, but its function there is largely unknown.
  • Mitochondrial ERbeta's role in cancer, particularly non-small-cell lung cancer (NSCLC), requires further investigation.

Purpose of the Study:

  • To elucidate the function of mitochondrial ERbeta in non-small-cell lung cancer (NSCLC) cells.
  • To determine if ERbeta's role in apoptosis is ligand-dependent or independent.

Main Methods:

  • Short hairpin RNA (shRNA) was used to down-regulate ERbeta in NSCLC cells.
  • Apoptosis-inducing agents (cisplatin, taxol, etoposide) were used to assess cell sensitivity.
  • Glutathione-S-transferase (GST) pull-down assays and molecular modeling were employed to study protein interactions.
  • Reintroduction of ERbeta into knockdown cells was performed to confirm findings.

Main Results:

  • ERbeta knockdown sensitized NSCLC cells to apoptosis-inducing agents, irrespective of estrogen.
  • Mitochondrial ERbeta physically interacted with the proapoptotic protein Bad in a ligand-independent manner.
  • ERbeta inhibited Bad function by disrupting its interactions with Bcl-xL and Bcl-2, thereby regulating apoptosis.

Conclusions:

  • Mitochondrial ERbeta plays a significant role in regulating apoptosis in NSCLC cells.
  • This function is ligand-independent, highlighting a novel role for ERbeta beyond its nuclear functions.
  • ERbeta's interaction with Bad offers a new therapeutic target for NSCLC treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...